244 related articles for article (PubMed ID: 27373819)
1. Longitudinal structural, functional, and cellular myocardial alterations with chronic centrifugal continuous-flow left ventricular assist device support.
Muthiah K; Humphreys DT; Robson D; Dhital K; Spratt P; Jansz P; Macdonald PS; Hayward CS
J Heart Lung Transplant; 2017 Jul; 36(7):722-731. PubMed ID: 27373819
[TBL] [Abstract][Full Text] [Related]
2. Myocardial Structural and Functional Response After Long-Term Mechanical Unloading With Continuous Flow Left Ventricular Assist Device: Axial Versus Centrifugal Flow.
Al-Sarie M; Rauf A; Kfoury AG; Catino A; Wever-Pinzon J; Bonios M; Horne BD; Diakos NA; Wever-Pinzon O; McKellar SH; Kelkhoff A; McCreath L; Fang J; Stehlik J; Selzman CH; Drakos SG
JACC Heart Fail; 2016 Jul; 4(7):570-576. PubMed ID: 27179831
[TBL] [Abstract][Full Text] [Related]
3. Biventricular assist device-induced right ventricular reverse structural and functional remodeling.
Klotz S; Naka Y; Oz MC; Burkhoff D
J Heart Lung Transplant; 2005 Sep; 24(9):1195-201. PubMed ID: 16143233
[TBL] [Abstract][Full Text] [Related]
4. Myocardial atrophy and chronic mechanical unloading of the failing human heart: implications for cardiac assist device-induced myocardial recovery.
Diakos NA; Selzman CH; Sachse FB; Stehlik J; Kfoury AG; Wever-Pinzon O; Catino A; Alharethi R; Reid BB; Miller DV; Salama M; Zaitsev AV; Shibayama J; Li H; Fang JC; Li DY; Drakos SG
J Am Coll Cardiol; 2014 Oct; 64(15):1602-12. PubMed ID: 25301465
[TBL] [Abstract][Full Text] [Related]
5. Comparison of right and left ventricular responses to left ventricular assist device support in patients with severe heart failure: a primary role of mechanical unloading underlying reverse remodeling.
Barbone A; Holmes JW; Heerdt PM; The' AH; Naka Y; Joshi N; Daines M; Marks AR; Oz MC; Burkhoff D
Circulation; 2001 Aug; 104(6):670-5. PubMed ID: 11489773
[TBL] [Abstract][Full Text] [Related]
6. Effects of continuous-flow versus pulsatile-flow left ventricular assist devices on myocardial unloading and remodeling.
Kato TS; Chokshi A; Singh P; Khawaja T; Cheema F; Akashi H; Shahzad K; Iwata S; Homma S; Takayama H; Naka Y; Jorde U; Farr M; Mancini DM; Schulze PC
Circ Heart Fail; 2011 Sep; 4(5):546-53. PubMed ID: 21765125
[TBL] [Abstract][Full Text] [Related]
7. Left ventricular assist device support normalizes left and right ventricular beta-adrenergic pathway properties.
Klotz S; Barbone A; Reiken S; Holmes JW; Naka Y; Oz MC; Marks AR; Burkhoff D
J Am Coll Cardiol; 2005 Mar; 45(5):668-76. PubMed ID: 15734609
[TBL] [Abstract][Full Text] [Related]
8. Normalisation of haemodynamics in patients with end-stage heart failure with continuous-flow left ventricular assist device therapy.
Gupta S; Woldendorp K; Muthiah K; Robson D; Prichard R; Macdonald PS; Keogh AM; Kotlyar E; Jabbour A; Dhital K; Granger E; Spratt P; Jansz P; Hayward CS
Heart Lung Circ; 2014 Oct; 23(10):963-9. PubMed ID: 24973864
[TBL] [Abstract][Full Text] [Related]
9. Myocardial sympathetic innervation and long-term left ventricular mechanical unloading.
Drakos SG; Athanasoulis T; Malliaras KG; Terrovitis JV; Diakos N; Koudoumas D; Ntalianis AS; Theodoropoulos SP; Yacoub MH; Nanas JN
JACC Cardiovasc Imaging; 2010 Jan; 3(1):64-70. PubMed ID: 20129533
[TBL] [Abstract][Full Text] [Related]
10. Effect of Continuous-Flow Mechanical Circulatory Support on Microvasculature Remodeling in the Failing Heart.
Saito T; Miyagawa S; Toda K; Yoshikawa Y; Fukushima S; Saito S; Yoshioka D; Sakata Y; Daimon T; Sawa Y
Artif Organs; 2019 Apr; 43(4):350-362. PubMed ID: 30129970
[TBL] [Abstract][Full Text] [Related]
11. Assessment of myocardial viability and left ventricular function in patients supported by a left ventricular assist device.
Gupta DK; Skali H; Rivero J; Campbell P; Griffin L; Smith C; Foster C; Claggett B; Glynn RJ; Couper G; Givertz MM; Mehra MR; Di Carli M; Solomon SD; Pfeffer MA
J Heart Lung Transplant; 2014 Apr; 33(4):372-81. PubMed ID: 24582837
[TBL] [Abstract][Full Text] [Related]
12. 3D Morphological Changes in LV and RV During LVAD Ramp Studies.
Addetia K; Uriel N; Maffessanti F; Sayer G; Adatya S; Kim GH; Sarswat N; Fedson S; Medvedofsky D; Kruse E; Collins K; Rodgers D; Ota T; Jeevanandam V; Mor-Avi V; Burkhoff D; Lang RM
JACC Cardiovasc Imaging; 2018 Feb; 11(2 Pt 1):159-169. PubMed ID: 28412431
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of 3-dimensional echocardiographical heart volume assessment in patients scheduled for left ventricular assist device implantation.
Otten A; Kurz S; Anwar S; Potapov E; Krall C; O'Brien B; Habazettl H; Krabatsch T; Kukucka M
Eur J Cardiothorac Surg; 2018 Jul; 54(1):169-175. PubMed ID: 29394347
[TBL] [Abstract][Full Text] [Related]
14. Magnitude and time course of changes induced by continuous-flow left ventricular assist device unloading in chronic heart failure: insights into cardiac recovery.
Drakos SG; Wever-Pinzon O; Selzman CH; Gilbert EM; Alharethi R; Reid BB; Saidi A; Diakos NA; Stoker S; Davis ES; Movsesian M; Li DY; Stehlik J; Kfoury AG;
J Am Coll Cardiol; 2013 May; 61(19):1985-94. PubMed ID: 23500219
[TBL] [Abstract][Full Text] [Related]
15. Brain natriuretic peptide is produced both by cardiomyocytes and cells infiltrating the heart in patients with severe heart failure supported by a left ventricular assist device.
Bruggink AH; de Jonge N; van Oosterhout MF; Van Wichen DF; de Koning E; Lahpor JR; Kemperman H; Gmelig-Meyling FH; de Weger RA
J Heart Lung Transplant; 2006 Feb; 25(2):174-80. PubMed ID: 16446217
[TBL] [Abstract][Full Text] [Related]
16. Reversal of metallothionein expression is different throughout the human myocardium after prolonged left-ventricular mechanical support.
Baba HA; Grabellus F; August C; Plenz G; Takeda A; Tjan TD; Schmid C; Deng MC
J Heart Lung Transplant; 2000 Jul; 19(7):668-74. PubMed ID: 10930816
[TBL] [Abstract][Full Text] [Related]
17. Early trends in N-terminal pro-brain natriuretic peptide values after left ventricular assist device implantation for chronic heart failure.
Hasin T; Kushwaha SS; Lesnick TG; Kremers W; Boilson BA; Schirger JA; Clavell AL; Rodeheffer RJ; Frantz RP; Edwards BS; Pereira NL; Stulak JM; Joyce L; Daly R; Park SJ; Jaffe AS
Am J Cardiol; 2014 Oct; 114(8):1257-63. PubMed ID: 25194171
[TBL] [Abstract][Full Text] [Related]
18. Myocardial size and fibrosis changes during left ventricular assist device support.
Yamada Y; Saito S; Nishinaka T; Yamazaki K
ASAIO J; 2012; 58(4):402-6. PubMed ID: 22739784
[TBL] [Abstract][Full Text] [Related]
19. Myocardial fibrosis and pro-fibrotic markers in end-stage heart failure patients during continuous-flow left ventricular assist device support.
Lok SI; Nous FM; van Kuik J; van der Weide P; Winkens B; Kemperman H; Huisman A; Lahpor JR; de Weger RA; de Jonge N
Eur J Cardiothorac Surg; 2015 Sep; 48(3):407-15. PubMed ID: 25609773
[TBL] [Abstract][Full Text] [Related]
20. Durable ventricular assist device support for failing systemic morphologic right ventricle: early results.
Peng E; O'Sullivan JJ; Griselli M; Roysam C; Crossland D; Chaudhari M; Wrightson N; Butt T; Parry G; MacGowan GA; Schueler S; Hasan A
Ann Thorac Surg; 2014 Dec; 98(6):2122-9. PubMed ID: 25443016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
